Similar articles

• DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior.

  Volm M, Mattern J, Sonka J, Vogt-Schaden M, Wayss K. Volm M, et al. Cytometry. 1985 Jul;6(4):348-56. doi: 10.1002/cyto.990060412. Cytometry. 1985. PMID: 2990835
• [Flow cytometric analysis of DNA content in lung cancer].

  Liu GX. Liu GX. Zhonghua Jie He He Hu Xi Za Zhi. 1992 Oct;15(5):290-2, 320. Zhonghua Jie He He Hu Xi Za Zhi. 1992. PMID: 1339110 Chinese.
• Flow cytometric analysis of human lung cancer. Correlation with histologic type and stage.

  Moran RE, Melamed MR. Moran RE, et al. Anal Quant Cytol. 1984 Jun;6(2):99-104. Anal Quant Cytol. 1984. PMID: 6205621
• [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature].

  Jeanfaivre T, Chassevent A, Larra F, Tuchais E. Jeanfaivre T, et al. Bull Cancer. 1994 Jul;81(7):605-9. Bull Cancer. 1994. PMID: 7742603 Review. French.
• DNA flow cytometric analysis in patients with operable non-small cell lung carcinoma.

  Granone P, Cardillo G, Rumi E, D'Ugo D, Rumi C, Ciletti S, Margaritora S, Terribile D, Picciocchi A. Granone P, et al. Eur J Cardiothorac Surg. 1993;7(7):351-5. doi: 10.1016/1010-7940(93)90065-j. Eur J Cardiothorac Surg. 1993. PMID: 8396951 Review.